Visual Abstract

Graphic Abstract

Introduction: Switch from hemodialysis (HD) to peritoneal dialysis (PD) is unfrequent, but incentive strategies to perform PD can lead to an increase of these transitions. However, data on transitioning from HD to PD are scarce. We hypothesized that time spent on HD before transfer to PD would impact PD outcomes. Methods: This registry-based, nationwide study analyzed patients transferred from HD to PD. Patients who began HD between January 2008 and December 2016 were included. Cox and Fine and Gray regression models were used to explore the relationship between time spent on HD before PD and outcomes in PD: PD cessation for death or retransfer to HD (composite endpoint); for death; and for retransfer to HD. Results: Over the study period, 1,985 of the 77,587 HD starters (3%) were transferred to PD. The median time spent on HD before transfer to PD was 1.94 months (interquartile range [IQR] 1.02–4.01). The median survival time on PD after this transition was 20 months (IQR 18–21). Time spent on HD before PD was associated with increased risk of death or retransfer to HD (cause-specific hazard ratio [cs-HR] 1.01, 95% confidence interval [CI]: 1–1.02 for a 1-month increase) and death (cs-HR 1.02, 95% CI: 1.01–1.03) but not with retransfer to HD censored on death (cs-HR 1.00, 95% CI: 0.99–1.01). The results were similar when considering competing events. Discussion/Conclusion: Switch from HD to PD is rare in France. Time spent on HD before transfer is associated with patient survival but not with retransfer to HD.

1.
INTEGRATED Group consists of (in alphabetical order)
,
Chan
C
,
Combes
G
,
Davies
S
,
Finkelstein
F
,
Firanek
C
,
Transition between different renal replacement modalities: gaps in knowledge and care-the integrated research initiative
.
Perit Dial Int
.
2019 Feb
;
39
(
1
):
4
12
.
2.
REIN
.
Rapport annuel 2018
.
2018
. Available from: https://www.agence-biomedecine.fr/IMG/pdf/rapport_rein_2018_v2.pdf.
3.
Sloan
CE
,
Coffman
CJ
,
Sanders
LL
,
Maciejewski
ML
,
Lee
SYD
,
Hirth
RA
,
Trends in peritoneal dialysis use in the United States after medicare payment reform
.
Clin J Am Soc Nephrol
.
2019 Dec
;
14
(
12
):
1763
72
.
4.
Blake
PG
,
McCormick
BB
,
Taji
L
,
Jung
JK
,
Ip
J
,
Gingras
J
,
Growing home dialysis: the Ontario renal network home dialysis initiative 2012–2019
.
Perit Dial Int
.
2021 Sep
;
41
(
5
):
441
52
.
5.
Van Biesen
W
,
Vanholder
RC
,
Veys
N
,
Dhondt
A
,
Lameire
NH
.
An evaluation of an integrative care approach for end-stage renal disease patients
.
J Am Soc Nephrol
.
2000 Jan
;
11
(
1
):
116
25
. .
6.
Zhang
L
,
Cao
T
,
Li
Z
,
Wen
Q
,
Lin
J
,
Zhang
X
,
Clinical outcomes of peritoneal dialysis patients transferred from hemodialysis: a matched case-control study
.
Perit Dial Int
.
2013 Jun
;
33
(
3
):
259
66
.
7.
Nguyen
ANL
,
Prasad Kafle
M
,
Sud
K
,
Lee
VW
.
Predictors and outcomes of patients switching from maintenance haemodialysis to peritoneal dialysis in Australia and New Zealand: strengthening the argument for “peritoneal dialysis first” policy
.
Nephrology
.
2019 Sep
;
24
(
9
):
958
66
.
8.
Barone
RJ
,
Cámpora
MI
,
Gimenez
NS
,
Ramirez
L
,
Panese
SA
,
Santopietro
M
.
Peritoneal dialysis as a first versus second option after previous haemodialysis: a very long-term assessment
.
Int J Nephrol
.
2014
;
2014
:
693670
. .
9.
Najafi
I
,
Hosseini
M
,
Atabac
S
,
Sanadgol
H
,
Majelan
NN
,
Seirafian
S
,
Patient outcome in primary peritoneal dialysis patients versus those transferred from hemodialysis and transplantation
.
Int Urol Nephrol
.
2012 Aug
;
44
(
4
):
1237
42
.
10.
Koc
Y
,
Unsal
A
,
Basturk
T
,
Sakaci
T
,
Ahbap-Dal
E
,
Sinangil-Arar
A
,
Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?
Nefrologia
.
2012 May
;
32
(
3
):
335
42
.
11.
Liberek
T
,
Renke
M
,
Skonieczny
B
,
Kotewicz
K
,
Kowalewska
J
,
Chmielewski
M
,
Therapy outcome in peritoneal dialysis patients transferred from haemodialysis
.
Nephrol Dial Transplant
.
2009 Sep
;
24
(
9
):
2889
94
.
12.
Wang
J
,
Zeng
J
,
Liu
B
,
Cai
B
,
Li
Y
,
Dong
L
.
Outcomes after transfer from hemodialysis to peritoneal dialysis vs peritoneal dialysis as initial therapy: a systematic review and meta-analysis
.
Semin Dial
.
2020 Jul
;
33
(
4
):
299
308
. .
13.
Nessim
SJ
,
Bargman
JM
,
Jassal
SV
,
Oliver
MJ
,
Na
Y
,
Perl
J
.
The impact of transfer from hemodialysis on peritoneal dialysis technique survival
.
Perit Dial Int
.
2015 Jun
;
35
(
3
):
297
305
. .
14.
Béchade
C
,
Guittet
L
,
Evans
D
,
Verger
C
,
Ryckelynck
JP
,
Lobbedez
T
.
Early failure in patients starting peritoneal dialysis: a competing risks approach
.
Nephrol Dial Transplant
.
2014 Nov
;
29
(
11
):
2127
35
. .
15.
Lan
PG
,
Clayton
PA
,
Johnson
DW
,
McDonald
SP
,
Borlace
M
,
Badve
SV
,
Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: proposal for a standardized definition of technique failure
.
Perit Dial Int
.
2016 12
;
36
(
6
):
623
30
.
16.
Royston
P
,
Parmar
MK
.
Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
.
Stat Med
.
2002 Aug
;
21
(
15
):
2175
97
. .
17.
Jansen
JP
.
Network meta-analysis of survival data with fractional polynomials
.
BMC Med Res Methodol
.
2011 May
;
11
:
61
. .
18.
Lau
B
,
Cole
SR
,
Gange
SJ
.
Competing risk regression models for epidemiologic data
.
Am J Epidemiol
.
2009 Jul
;
170
(
2
):
244
56
. .
19.
Fine
JP
,
Gray
RJ
.
A proportional hazards model for the subdistribution of a competing risk
.
J Am Stat Assoc
.
1999 Jun
;
94
(
446
):
496
509
. .
20.
White
IR
,
Royston
P
,
Wood
AM
.
Multiple imputation using chained equations: issues and guidance for practice
.
Stat Med
.
2011 Feb
;
30
(
4
):
377
99
. .
21.
Boissinot
L
,
Landru
I
,
Cardineau
E
,
Zagdoun
E
,
Ryckelycnk
JP
,
Lobbedez
T
.
Is transition between peritoneal dialysis and hemodialysis really a gradual process?
Perit Dial Int
.
2013 Aug
;
33
(
4
):
391
7
. .
22.
Sumida
K
,
Yamagata
K
,
Iseki
K
,
Tsubakihara
Y
.
Different impact of hemodialysis vintage on cause-specific mortality in long-term hemodialysis patients
.
Nephrol Dial Transplant
.
2016 Feb
;
31
(
2
):
298
305
. .
23.
Iseki
K
,
Tozawa
M
,
Takishita
S
.
Effect of the duration of dialysis on survival in a cohort of chronic haemodialysis patients
.
Nephrol Dial Transplant
.
2003 Apr
;
18
(
4
):
782
7
. .
24.
Chertow
GM
,
Johansen
KL
,
Lew
N
,
Lazarus
JM
,
Lowrie
EG
.
Vintage, nutritional status, and survival in hemodialysis patients
.
Kidney Int
.
2000 Mar
;
57
(
3
):
1176
81
. .
25.
Yeates
K
,
Zhu
N
,
Vonesh
E
,
Trpeski
L
,
Blake
P
,
Fenton
S
.
Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada
.
Nephrol Dial Transplant
.
2012 Sep
;
27
(
9
):
3568
75
. .
26.
Imbeault
B
,
Nadeau-Fredette
AC
.
Optimization of dialysis modality transitions for improved patient care
.
Can J Kidney Health Dis
.
2019
;
6
:
2054358119882664
. .
27.
Bargman
JM
,
Thorpe
KE
,
Churchill
DN
.
Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study
.
J Am Soc Nephrol
.
2001 Oct
;
12
(
10
):
2158
62
. .
28.
Perl
J
,
Bargman
JM
.
The importance of residual kidney function for patients on dialysis: a critical review
.
Am J Kidney Dis
.
2009 Jun
;
53
(
6
):
1068
81
. .
29.
Misra
M
,
Vonesh
E
,
Van Stone
JC
,
Moore
HL
,
Prowant
B
,
Nolph
KD
.
Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis
.
Kidney Int
.
2001 Feb
;
59
(
2
):
754
63
. .
30.
Jansen
MAM
,
Hart
AAM
,
Korevaar
JC
,
Dekker
FW
,
Boeschoten
EW
,
Krediet
RT
,
Predictors of the rate of decline of residual renal function in incident dialysis patients
.
Kidney Int
.
2002 Sep
;
62
(
3
):
1046
53
.
31.
Termorshuizen
F
,
Korevaar
JC
,
Dekker
FW
,
van Manen
JG
,
Boeschoten
EW
,
Krediet
RT
,
The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD )-2
.
Am J Kidney Dis
.
2003 Jun
;
41
(
6
):
1293
302
.
32.
Lobbedez
T
,
Verger
C
,
Ryckelynck
JP
,
Fabre
E
,
Evans
D
.
Is assisted peritoneal dialysis associated with technique survival when competing events are considered?
Clin J Am Soc Nephrol
.
2012 Apr
;
7
(
4
):
612
8
. .
33.
Béchade
C
,
Lobbedez
T
,
Ivarsen
P
,
Povlsen
JV
.
Assisted peritoneal dialysis for older people with end-stage renal disease: the French and Danish experience
.
Perit Dial Int
.
2015 Nov
;
35
(
6
):
663
6
. .
34.
Lanot
A
,
Bechade
C
,
Boyer
A
,
Ficheux
M
,
Lobbedez
T
.
Assisted peritoneal dialysis and transfer to haemodialysis: a cause-specific analysis with data from the RDPLF
.
Nephrol Dial Transplant
.
2021 Jan
;
36
(
2
):
330
9
. .
35.
Ravani
P
,
Palmer
SC
,
Oliver
MJ
,
Quinn
RR
,
MacRae
JM
,
Tai
DJ
,
Associations between hemodialysis access type and clinical outcomes: a systematic review
.
J Am Soc Nephrol
.
2013 Feb
;
24
(
3
):
465
73
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.